Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

University announces £10m investment in animal science
The deal will bring to market new veterinary vaccines and tools for diagnosing diseases that affect farmed animals.

Deal will bring new veterinary vaccines to market

The University of Edinburgh has secured an investment of £10 million to bring animal science innovations to market.

The investment in a new company, Roslin Technologies, will develop business opportunities arising from research from the University of Edinburgh’s Roslin Institute and Royal (Dick) School of Veterinary Studies.

The deal will enable researchers to explore the commercial potential of technologies that enable low-cost manufacturing of new medicines using chicken eggs.

It will also bring to market new veterinary vaccines and tools for diagnosing diseases that affect farmed animals.

“This investment recognises the strength of the University’s innovation capacity and cements our position as one of the world’s leading research-intensive universities,” said Sir Timothy O’Shea, principal and vice-chancellor of the University of Edinburgh.

Professor Bruce Whitelaw, interim director of The Roslin Institute, added: “The Roslin Institute is internationally recognised for providing a strategic research base for large animal genetics and health science within the UK.

“Having pioneered the commercialisation of animal biotechnology for three decades, the establishment of Roslin Technologies now provides an exciting platform to accelerate the translation of Roslin’s data-driven innovations into the commercial sector.”

Roslin Technologies Ltd is thought to be the largest agriculture biotechnology start-up in UK history to focus on research projects aimed at improving animal health and raising agricultural productivity.

The company is a collaboration between the University, private equity advisors JB Equity and the British Innovation Fund, a newly-formed fund that invests in leading innovation venture funds and companies from British universities.

Image (C) University of Edinburgh

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.